Overview of dialyzer elution studies: Impact on current views on bioincompatibility and future perspectives

Netherlands Journal of Medicine

Volumn 52, Issue 5, 1998, Pages 160-168

  Nube M J ^a   Grooteman, M P C ^a  

^a Northwest Clinics   (Netherlands)

Author keywords

Elution; Halmo hemodialysis; Lymphocyte; Monocyte; Polymorphonuclear cell

Indexed keywords

ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; HEMATOCRIT; HEMODIALYSIS; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE; MONOCYTE;

BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL COUNT; CELL DEGRANULATION; CELL DIFFERENTIATION; HUMANS; LYMPHOCYTES; MEMBRANES, ARTIFICIAL; MONOCYTES; RENAL DIALYSIS;

EID: 0032078431     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(98)00013-8     Document Type: Article

References (54)

1. [1] Panichi V, Casarosa L, Gattai V, Bianchi AM, Andreini B, Migliori M, De Pietro S, Giovannini L, Palla R. Protein layer on hemodialysis membranes: a new immunohistochemistry technique. Int J Artif Organs 1995;18:305-308.
2. [2] Cheung KC, Parker CJ, Wilcox L, Janatova J. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int 1989;36:257-265.
3. [3] Pascual M, Schifferli JA. Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1994;43:903-913.
4. [4] Leonard EF, van Vooren C, Hauglustaine D, Haumont S. Shear-induced formation of aggregates during hemodialysis. Contrib Nephrol 1983;36:34-45.
5. [5] Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane contact in haemodialysis-induced granulocyte activation. Nephron 1991;57:64-68.
6. [6] Haeffner-Cavaillon N, Cavaillon JM, Laude M, Kazatchkine MD. C3a (C3adesArg) induces production and release of interleukin-1 by cultured human monocytes. J Immunol 1987;139:794-799.
7. [7] Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro. J Clin Invest 1977;60:260-264.
8. [8] Kuwahara T, Markert M, Wauters JP. Proteins adsorbed on hemodialysis membranes modulate neutrophil activation. Artif Organs 1989;13:427-431.
9. [9] Laude-Sharp SM, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis: trans-membrane passage of intact endotoxins (LPS). Kidney Int 1990;38:1089-1094.
10. [10] Bingel M, Koch KM, Lonneman G, Dinarello CA, Shaldon S. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1987;ii:14-16.
11. [11] Grooteman MPC, Nubé MJ, Bos JC, van Limbeek J, Schoorl M, Van Houte AJ. Ex vivo elution of hemodialyzers: an additional criterion for the assessment of bioincompatibility. Blood Purif 1996;14:421-430.
12. [12] Grooteman MPC, Nubé MJ, van Houte AJ, Schoorl M, van Limbeek J. Granulocyte sequestration in dialyzers, a comparitive study of three different membranes. Nephrol Dial Transplant 1995;10:1859-1864.
13. [13] Grooteman MPC, Bos JC, van Houte AJ, van Limbeek J, Schoorl M, Nubé MJ. Mechanisms of intra-dialyser granulocyte sequestration: a sequential elution study. Nephrol Dial Transplant 1997;12:492-499.
14. [14] Bos JC, Grooteman MPC, Schoorl M, van Limbeek J, van Houte AJ, Nubé MJ. Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin. Nephrol Dial Transplant 1997;7:1387-1394.
15. [15] Schouten WEM, Nubé MJ, Grooteman MPC, Schoorl M, van Houte AJ. Evidence for monocytic activation in dialyzer eluates. Neth J Med 1996;48:A68-A69.
16. [16] Schouten WEM, Nubé MJ, Grooteman MPC, Daha MR, Schoorl M, van Houte AJ. Gene expression of IL-1β in dialyzer eluates. Neth J Med 1996;48:A69.
17. [17] Grooteman MPC, Nubé MJ, van Limbeek J, Schoorl M, van Houte AJ. Lymphocyte subsets in dialyzer eluates: a new parameter of bio-incompatibility?. Nephrol Dial Transplant 1996;11:1073-1078.
18. [18] Grooteman MPC, Nubé MJ, van Limbeek J, van Houte AJ, Daha MR, van Geelen AJ. Biocompatibility and performance of a modified cellulosic and a synthetic high-flux dialyzer: a randomized cross-over comparison between cellulose triacetate and polysulfon. ASAIO J 1995;41:215-220.
19. [19] Johnson RJ. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994;9(Suppl 2):36-45.
20. [20] Bos JC, Grooteman MPC, van Houte AJ, Schoorl M, Nubé MJ. Circulating rather than adherent PMN are responsible for intra-dialyzer degranulation during haemodialysis. Neth J Med 1996;48:A65-A66.
21. [21] Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. J Am Med Assoc 1968;203:133-135.
22. [22] Woffindin C, Hoenich NA, Matthews JNS. Cellulose-based haemodialysis membranes: biocompatibility and functional performance compared. Nephrol Dial Transplant 1992;7:340-345.
23. [23] Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984;26:194-200.
24. [24] Tielemans CL, Delville JPC, Husson CP, Madhoun P, Lambrechts AM, Goldman M, Vanherweghem JL. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993;39:158-165.
25. [25] Rabb H, Agosti SJ, Bittle A. Alterations in soluble and leukocyte surface 1-selectin (CD62L) in haemodialysis patients. J Am Soc Nephrol 1995;6:1445-1450.
26. [26] Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
27. [27] Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985;312:457-462.
28. [28] Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and MAC-1 during dialysis: a prospective, randomized controlled trial. Kidney Int 1992;41:388-395.
29. [29] Alvarez V, Pulido R, Campanero MR, Paraiso V, de Landázuri MO, Sánchez-Madrid F. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 1991;40:899-905.
30. [30] Schaefer RM, Heidland A, Hörl WH. Effect of dialyzer geometry on granulocyte and complement activation. Am J Nephrol 1987;7:121-126.
31. [31] Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991;40:1123-1133.
32. [32] Henderson L, Koch K, Dinarello C, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1983;1:3-8.
33. [33] Pereira BJG. Cytokine production in patients on dialysis. Blood Purif 1995;13:135-146.
34. [34] Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990;37:85-93.
35. [35] Grooteman MPC, Nubé MJ, Daha MR, van Limbeek J, van Deuren M, Schoorl M, Bet PM, van Houte AJ. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes, J Am Soc Nephrol 1997;8:1745-1754.
36. [36] Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM. Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993;43:712-721.
37. [37] Tielemans C, Delville JP, Husson C, et al. CD11b and CD45 on monocytes (MNC) during hemodialysis (HD). J Am Soc Nephrol 1991;2:352.
38. [38] Herbelin A, Ureña P, Nguyen A, Zingraff J, DescampsLatscha B. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumor necrosis factor α by circulating monocytes. Nephrol Dial Transplant 1991;6:349-357.
39. [39] Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 1988;140:1690-1694.
40. [40] Roitt IM, Brostoff J, Male DK. In: Immunology. 3rd ed. London: Mosby, 1993:2.2.
41. [41] Chida Y, Sakurai S, Yoshiyama N. The effect of hemodialysis on lymphocyte subsets during dialysis. Clin Nephrol 1986;25:159-163.
42. [42] Morra L, Ponassi GA, Gurreri G, Moccia F, Mela F, Bessone G. T-lymphocyte subsets in chronic uremic patients treated with maintenance hemodialysis. Biomed Pharmacother 1990;44:53-56.
43. [43] Ueki Y, Nagata M, Miyake S, Tominaga Y. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin. J Clin Immunol 1993;13:279-287.
44. [44] Zaoui P, Hakim RM. Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int 1993;43:1298-1305.
45. [45] Pisa P, Jira M, Horky J, Strejcek J, Valek A. Depression in spontaneous cell-mediated cytotoxicity occurs during hemodialysis. Clin Nephrol 1987;27:289-292.
46. [46] Degiannis D, Czarnecki M, Donati D, Homer L, Eisinger RP, Raska K, Raskova J. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfon membranes. Am J Nephrol 1990;10:276-282.
47. [47] López San Martín M, De Francisco ALM, González M, Ruiz JC, Prieto M, Sanz de Castro S, Arias M. Lymphocyte activation in CRF patients and biocompatibility of dialysis membranes and techniques. Blood Purif in Perspective II. ICAIOT Press, 1992;320:223-229.
48. [48] Hörl WH, Heidland A. Evidence for the participation of granulocyte proteinases on intradialytic catabolism. Clin Nephrol 1984;21:314-322.
49. [49] Van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis. Kidney Int 1991;39:1012-1019.
50. 2-microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant 1988;3:284-290.
51. [51] Baurmeister U, Vienken J, Daum V. High-flux dialysis membranes: endotoxin transfer by backfiltration can be a problem. Nephrol Dial Transplant 1989;4(Suppl):89-93.
52. [52] Bigazzi R, Atti M, Baldari G. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination. Blood Purif 1990;8:190-198.
53. [53] Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis membranes: small-versus large-pore membranes. Nephrol Dial Transplant 1992;7:333-339.
54. [54] Lysaght MJ. Evolution of hemodialysis membranes. Contrib Nephrol 1995;113:1-10.